Showing 1 - 10 of 89
We are pleased to announce that the publication of the 2021 edition of The Legal 500 UK has seen us ranked as a ‘top-tier firm’ in nine practice areas.
When countries with well-developed health systems scrambled to purchase life-saving ventilators at the start of the COVID-19 crisis it illustrated just how serious the pandemic would be. Working on a war footing, governments from France to Germany, the UK and the US asked industry to produce ventilators and personal protective equipment at speed.
Best practice is slipping in clinical trials as the scientific community races to respond to Covid-19. Chubb and Kennedys consider the risks that are emerging as a result and how they can be mitigated.
Case review 2020-07-13
Product liability and the CPA: failure to consider product risks and benefits is all risk and no benefit
On 3 July 2020, Lambert J handed down judgment in the long standing Seroxat group litigation, Bailey and others v GlaxoSmithKline.
As smart devices become more and more integral to our personal day to day lives, the cyber-security risks to our data and privacy are also becoming more personal.
The results of Part 2 of the Law Commissions’ joint consultation into the regulation of automated vehicles, “emphasised how uncertain the future has become, and how regulation must be sufficiently flexible to deal with a wide variety of eventualities.”
Whatever the jurisdiction, companies should be adequately prepared to initiate a robust product recall.
On 13 February 2020, the Food Standards Agency (FSA) published guidance on the regulation of products for consumption containing cannabidiol (CBD).
Case review 2020-05-04
In a reminder of the scrutiny to which the courts will use when reviewing costs budgets, the High Court has rejected an application by group litigation claimants to retrospectively revise a previously approved costs budget and reduced a future budget by more than half.